LSPN Fall Conference to Equip Attendees with Strategies for Patent Protection in the Life Sciences Industry
San Francisco, CA, August 9, 2024 – As the life science industry continues to push the boundaries of innovation, safeguarding intellectual property has become a crucial component for maximizing impact and return on investment. This October, industry leaders will gather at the Life Sciences Patent Network (LSPN) Fall Conference to discuss the most effective strategies for bulletproofing patents at every stage of the life cycle.
Taking place at the Hyatt Regency in San Francisco’s Embarcadero district on October 15-16, the LSPN Fall Conference offers a unique opportunity for industry professionals to come together and address current challenges and solutions. The recently updated agenda highlights the topics that will be covered during the event.
Delegates will have the opportunity to learn from real case studies presented by some of the most innovative and prominent companies in the industry. Attendees will leave with a clear blueprint for success as thought leaders share the strategies and tactics they have used to stay ahead of competitors. When asked why she continues to attend the LSPN conference, chairperson Eldora Ellison, Director at Sterne Kessler, stated, “The LSPN conference provides a unique opportunity to gain in-depth knowledge on the cutting-edge issues that are most relevant to my practice. LSPN gives attendees a deep dive into patent law issues that impact practitioners in the life sciences industry in both the US and globally. Additionally, LSPN offers an unparalleled opportunity to network with colleagues and engage in small-group dialogues during the numerous round-table discussions.”
Attendees can expect to:
– Join the discussion on the latest innovations and learn how to protect them from industry leaders at Pfizer, Bristol Myers Squibb, BioMarin, 10x Genomics, City of Hope, and Illumina through keynote presentations and panel discussions.
– Hear from Randy Wu, Vice President of Intellectual Property and Litigation at 10x Genomics, Betsy Haane, Senior Vice President of Intellectual Property at IGM Biosciences, and Anand Viswanathan, Director of Intellectual Property at BioMarin Pharmaceuticals.
– Dive into pressing issues such as artificial intelligence, effective prosecution and enforcement strategies, and multi-jurisdiction challenges with experts during roundtable discussions.
And much more.
For more information, please visit the event website.
We look forward to welcoming attendees to what promises to be the must-attend event for pharmaceutical and biotech patent owners this year.
Hannah Gore
Senior Conference Producer
World IP Review
hgore@newtonmedia.co.uk
Press Release Distributed by Pressat (https://pressat.co.uk/).
